Recall: D-0726-2026

Class II - Potentially Harmful

Class IIClassification

2026-07-16Initiated

OngoingStatus

Fresenius Kabi USA, LLCFirm

Product

Lidocaine HCl Injection, USP, 2%, 100 mg per 5 mL (20 mg per mL), 25 Single Dose Vials, 5 mL per vial, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-208-05; NDC Vial: 63323-208-01

Reason

Presence of Particulate Matter: Hair was found in products

Distribution

Nationwide within in the USA

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.